Sanofi will acquire Kadmon for $9.50 per share in cash, representing a total equity value of around $1.9bn
News
Gov’t injects £5.4bn to support NHS England’s COVID-19 response
Funds will be used over the next six months to tackle waiting lists and manage ‘immediate pressures’
ILC Therapeutics raises £3.5m to advance lead interferon drug candidate
Funds will be used for the development of hybrid interferon Alfacyte
Up to £16.8bn needed to clear NHS elective care backlog
New analysis from the Health Foundation’s REAL Centre warns extra support and investment needed
CMA launches formal investigation into COVID-19 PCR test firm
Expert Medicals – one of the largest PCR travel test providers in the UK this summer – has received a ‘high number of complaints’
Government launches OHID to tackle health inequalities
New government body will be co-led by deputy chief medical officer Jeanelle de Gruchy
New tezepelumab data shows improvements for severe asthma subgroup
TSLP blocker reduced exacerbations in patients with severe asthma and comorbid nasal polyps
JCVI does not recommend COVID-19 vaccination for all 12 to 15-year-olds
UK’s chief medical officers will now provide ‘further advice’ on COVID-19 vaccination in this age group
PMGroup Worldwide Ltd and The Datateam Media Group welcome Samedan Ltd
Samedan joining PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division
NICE recommends Novartis’ Cosentyx for children with severe psoriasis
The monoclonal antibody is designed to block IL-17A, a molecule involved in the psoriasis inflammatory response
Takeda’s blood cancer drug fails to achieve Phase III endpoint
Pevonedistat plus azacitidine did not meet primary endpoint of EFS
BMS opts-in on Evotec’s neurodegenerative medicine
Deal worth $20m plus potential $250m in milestone payments
Moderna submits its COVID-19 vaccine booster to the FDA
Trial showed ‘robust antibody responses’ against Delta variant
GSK’s shingles vaccine Shingrix gains UK license
Jab aimed at adults aged 50 years and older and those at increased risk
IQVIA launches AI-powered medical information contact centre
AI tech designed to improve patient and HCP experience
